PATENT CLAIM ANALYSIS

Application Number: 15743427
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["548", "263200"]

Abstract:
Provided herein are pyrrolomycin derivatives, which can be used to modulate Mcl-1, inhibit proliferation of bacteria and pathogens, as well as to treat infectious diseases and cancers.

Claim (Index 19):
The compound of any one of  claims 1  to  18 , wherein R 6  and R 8  are each independently F or Cl.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 1.19231
- Patent Class: 548.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13836743', '14707197', '13983747', '13984991', '15744922']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7344720432735425
- 35 USC 102 Novelty (BERT): 0.5007908323829564
- Combined Prediction Score: 0.711103922184484
- Mean Citation Score: 218.08078
- Max Citation Score: 222.3453
- Similarity Product: 144.69680577986242

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test